Data Science Funding Announcements & Notices

Data science and informatics funding announcements and notices are available from NCI and NIH programs. Browse below for opportunities, requests for information, notices, and initiatives.

Title FOA Organization Release Date Expire Date Purpose
The NCI Transition Career Development Award (K22 - Independent Clinical Trial Not Allowed) PAR-21-128 NCI This Funding Opportunity Announcement (FOA) represents the continuation of an NCI program to facilitate the transition of investigators in mentored, non-independent cancer research positions to… More
Tobacco Control Policies to Promote Health Equity (R01 Clinical Trial Optional) PAR-20-302 NCI The purpose of this Funding Opportunity Announcement (FOA) is to support observational or intervention research focused on reducing disparities in tobacco use and secondhand smoke (SHS) exposure in… More
Neural Regulation of Cancer (R21 Clinical Trial Not Allowed) PAR-19-354 NCI This Funding Opportunity Announcement (FOA) encourages collaborative, transdisciplinary research with both neuroscience and cancer elements, which together will advance current understanding of the… More
NCI Request for Information (RFI): Input on Development of an NCI Cancer Biomarker Data Aggregator NOT-CA-18-095 NCI N/A NCI Request Information RFI): Input Development an NCI Cancer Biomarker Data Aggregator Notice Number: NOT-CA-18-095 Key Dates Release Date: July 23, 2018 Response Date: October 20, 2018 Related… More
Notice of Intent to Publish a Funding Opportunity Announcement for The Early Detection Research Network: Biomarker Characterization Centers (U2C Clinical Trial Not Allowed) NOT-CA-21-050 NCI N/A The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for Biomarker Characterization Centers (BCCs), one of the three scientific units of the Early Detection Research… More
Notice of Expiration of RFA-CA-19-042, "Informatics Technology for Cancer Research Education Resource (UE5 Clinical Trial Not Allowed)" NOT-CA-20-060 NCI N/A Notice Expiration RFA-CA-19-042, Informatics Technology Cancer Research Education Resource UE5 Clinical Trial Allowed)" Notice Number: NOT-CA-20-060 Key Dates Release Date: 6, 2020 Related… More
Notice of Availability of Administrative Supplements for NCI Grant and Cooperative Agreement Awards to Support Pediatric Cancer Control Research Across the Lifespan (Admin Supp Clinical Trial Optional) NOT-CA-18-088 NCI N/A Notice Availability Administrative Supplements NCI Grant Cooperative Agreement Awards Support Pediatric Cancer Control Research Across Lifespan Admin Supp Clinical Trial Optional) Notice Number: NOT… More
Cancer Target Discovery and Development (CTD2) (U01 Clinical Trial Not Allowed) PAR-21-274 NCI Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) will support the program "Cancer Target Discovery and Development (CTD2, pronounced cee-tee-dee-squared… More
Research Centers for Cancer Systems Biology (U54 Clinical Trial Not Allowed) RFA-CA-21-048 NCI The National Cancer Institutes (NCI) Cancer Systems Biology Consortium (CSBC, https://csbconsortium.org/) supports the application of systems biology approaches to cancer research and includes U01… More
Tobacco Control Policies to Promote Health Equity (R21 Clinical Trial Optional) PAR-20-303 NCI The purpose of this Funding Opportunity Announcement (FOA) is to support observational or intervention research focused on reducing disparities in tobacco use and secondhand smoke (SHS) exposure in… More
Updated:
Vote below about this page’s helpfulness.
CAPTCHA Image CAPTCHA

Enter the characters shown in the image.